Viewing Study NCT02204293


Ignite Creation Date: 2025-12-25 @ 1:13 AM
Ignite Modification Date: 2026-02-25 @ 7:28 PM
Study NCT ID: NCT02204293
Status: TERMINATED
Last Update Posted: 2020-08-07
First Post: 2014-07-29
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Canakinumab for Treatment of Adult-onset Still's Disease
Sponsor: Charite University, Berlin, Germany
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Adult-Onset Still´s Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Adult-Onset Still´s Disease View
None Canakinumab View
None Joint involvement View
None AOSD View